Bosworth D M, Pietra A D, Farrell R F
Clin Orthop Relat Res. 1976 May(116):2-7.
At the present time, streptomycin represents a tremendous advance in the treatment of patients with these lesions. Streptomycin undoubtedly will be improved upon and superseded by some other agent in the future, giving us better control of this disease and possibly enabling us to eradicate it. In closed lesions streptomycin, in dosages of 90 grams in a period of 90 days, has failed to arrest the tuberculous process permanently. Failure of treatment with streptomycin suggests strongly the presence of a sequestrum, a thick-walled abscess, or inadequate surgery. Healing seems to be related to the duration of administration of streptomycin and not to the total dosage. In patients having sinuses, streptomycin should be continued after healing for a period at least half as long as the healing period itself. Surgical ankylosis, or resection of non-weight-bearing joints, is apparently as necessary now as it ever has been, but is much safer and more effective. Indeed, at times surgical attack is made possible only by the use of streptomycin.
目前,链霉素在这些病灶患者的治疗方面代表了巨大的进步。毫无疑问,链霉素在未来会被其他药物改进并取代,从而让我们能更好地控制这种疾病,甚至有可能将其根除。在闭合性病灶中,90天内使用90克链霉素的剂量未能永久阻止结核进程。链霉素治疗失败强烈提示存在死骨、厚壁脓肿或手术不充分。愈合似乎与链霉素的给药持续时间有关,而非总剂量。对于有窦道的患者,愈合后链霉素应继续使用一段至少为愈合期一半时长的时间。手术性关节强直或非负重关节切除术,显然如今和以往一样必要,但更为安全且有效。实际上,有时只有使用链霉素才使得手术成为可能。